SCHEMBL5196180

SCHEMBL5196180

CC(=O)ONS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
MMP1 P03956 1/20 0.55
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
MMP13 P45452 1/20 0.55
LMNA P02545 2/20 0.53
POLB P06746 1/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 1/20 0.53
GAA P10253 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
IDO1 P14902 1/20 0.47
TSHR P16473 1/20 0.47
ALDH1A1 P00352 5/20 0.47
RAB9A P51151 1/20 0.46
PKM P14618 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28430487 0.84 CA1 (0.53) CA1CA2MMP1MMP2MMP9
SCHEMBL2026104 0.83 BCAT1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL11097924 0.82 POLB (0.59) CA1CA2MMP1MMP2MMP9
SCHEMBL7383385 0.82 MMP2 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL30825673 0.82 MMP2 (0.61) CA1CA2MMP1MMP2MMP9
SCHEMBL27903861 0.81 BCAT1 (0.53) CA1CA2MMP1MMP2MMP9
SCHEMBL522132 0.80 SMN1; SMN2 (0.54) CA1CA2LMNAKMT2AGAA
SCHEMBL28430488 0.80 CA1 (0.49) CA1CA2MMP1MMP2MMP9
SCHEMBL23852661 0.78 KMT2A (0.52) CA1CA2MMP1MMP2MMP9
SCHEMBL966452 0.77 CA1 (0.43) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812073-A1 DELIVERY SYSTEM FOR TOPICALLY APPLIED COMPOUNDS LIPO CHEMICALS INC (US) 2007-08-01 EP claimed
WO-2006036557-A1 DELIVERY SYSTEM FOR TOPICALLY APPLIED COMPOUNDS LIPO CHEMICALS, INC. (US) 2006-04-06 WO claimed
EP-1140033-A2 IMPROVED CONTROLLED RELEASE COMPOSITIONS AND METHOD AMCOL INTERNATIONAL CORPORATION (US) 2001-10-10 EP claimed
WO-2000041528-A9 IMPROVED CONTROLLED RELEASE COMPOSITIONS AND METHOD AMCOL INTERNATIONAL CORP (US) 2001-07-12 WO claimed
WO-2000041528-A2 IMPROVED CONTROLLED RELEASE COMPOSITIONS AND METHOD AMCOL INTERNATIONAL CORPORATION (US) 2000-07-20 WO claimed
WO-2023072246-A1 PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-05-04 WO disclosed
WO-2023072257-A1 PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-05-04 WO disclosed
WO-2023072240-A1 PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-05-04 WO disclosed
CN-113727983-A Fused bicyclic heterocyclic derivatives as pest control agents 拜耳公司 2021-11-30 CN disclosed